Harbour Antibodies BV, a leading player in the biotechnology sector, is headquartered in the Netherlands and operates extensively across Europe and North America. Founded in 2011, the company has established itself as a pioneer in the development of innovative antibody-based solutions for research and therapeutic applications. Specialising in custom monoclonal antibodies, Harbour Antibodies offers unique services that include the generation of high-affinity antibodies tailored to specific targets. Their proprietary technologies and commitment to quality have positioned them as a trusted partner in the life sciences industry. With a strong focus on advancing antibody engineering, Harbour Antibodies BV has achieved significant milestones, including collaborations with prominent research institutions and biopharmaceutical companies, solidifying its reputation as a key contributor to the field of immunology.
We don't have data for Harbour Antibodies BV, but we can show you information about their parent organization instead.
View parent company